Global Enteral Feeding Formula Market Strategies 2024, Forecast To 2033
20 Feb, 2024
The enteral feeding formula market has shown strong growth, increasing from $6.02 billion in 2023 to $6.61 billion in 2024, with a CAGR of 9.7%. The forecast predicts rapid growth, reaching $9.68 billion in 2028 with a CAGR of 10.0%. Growth drivers include a rising geriatric population, increased prevalence of chronic diseases, technological advancements in enteral feeding formula, growing awareness of clinical nutrition, and the expansion of home healthcare services. Major trends in the forecast period include the development of disease-specific enteral feeding formulas, demand for plant-based and organic formulas, a focus on immunonutrition in enteral feeding, customized enteral nutrition solutions, and the adoption of blenderized tube feeding formulas.
Global Enteral Feeding Formula Market Key Driver
The growing geriatric population worldwide is driving the demand for enteral feeding formulas. With projections indicating a substantial increase in the global population aged 60 years and above, there is a corresponding rise in the demand for enteral feeding formulas to address the nutritional needs of the elderly.
Get A Free Sample Of The Global Enteral Feeding Formula Market ReportGlobal Enteral Feeding Formula Market Segments
The enteral feeding formula market covered in this report is segmented –
1)By Product: Standard Formulas, Disease-Specific Formulas
2)By Stage: Adults, Pediatrics
3)By Application: Oncology, Gastroenterology, Neurology, Diabetes, Critical Care, Other Applications
4)By End User: Hospitals, Long-Term Care Facilities
By Geography: The regions covered in the template market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions.
North America was the largest region in the enteral feeding formula market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enteral feeding formula market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Enteral Feeding Formula Industry Players
Abbott Laboratories; Nestlé S. A.; Danone S. A.; Fresenius Kabi AG; Mead Johnson Nutrition Company; B. Braun Melsungen AG; Meiji Holdings Co. Ltd.; Real Food Blends; Ajinomoto Cambrooke Inc.; Otsuka Pharmaceutical Co. Ltd.; Hormel Foods Corporation; Meiji Seika Pharma Co. Ltd.; Medtrition Inc.; Nutri-Force Nutrition; Global Health Product Inc.; VICTUS; Primus Pharmaceuticals Inc.; Kate Farms; Baxter International Inc.; Perrigo Nutritionals LLC; Reckitt Benckiser Group plc; Royal Numico NV; Bio-Serv Inc.; Nutrabalace Ltd.; ProSynbiotics; Med-Diet Laboratories Inc.; Precision Foods-kent corporation; SimplyThick LLC; Coram LLC; Vitaflow LLC
Get The Full Global Enteral Feeding Formula Market Report
Enteral Feeding Formula Market Overview
The enteral feeding formulas are food formulations containing specific nutrients as per the need of the consumer. Patients who are in intensive care or are unable to swallow the food, need certain nutrients. The enteral feeding formulations can fulfil the nutrients and nutritional requirements. They are used for directly delivering the food or nutrients to the patient’s stomach or small intestine.
Enteral Feeding Formula Global Market Report 2023 provides data on the global enteral feeding formula market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The enteral feeding formula market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.